Helus Pharma Inc.
HELP | NASDAQ
$10.60
-$0.11 (-1.03%)
At close: Oct 30, 2026, 4:00 PM ET
$10.81
+$0.21 (+1.98%)
Pre-market:
Nov 2, 2026, 7:17 AM ET
Fiscal Quarter Period Ending | Q1 2027 Jun 30, 2026 | Q4 2026 Mar 31, 2026 | Q3 2026 Dec 31, 2025 | Q2 2026 Sep 30, 2025 | Q1 2026 Jun 30, 2025 | Q4 2025 Mar 31, 2025 | Q3 2025 Dec 31, 2024 | Q2 2025 Sep 30, 2024 | Q1 2025 Jun 30, 2024 | Q4 2024 Mar 31, 2024 | Q3 2024 Dec 31, 2023 | Q2 2024 Sep 30, 2023 | Q1 2024 Jun 30, 2023 | Q4 2023 Mar 31, 2023 | Q3 2023 Dec 31, 2022 | Q2 2023 Sep 30, 2022 | Q1 2023 Jun 30, 2022 | Q4 2022 Mar 31, 2022 | Q3 2022 Dec 31, 2021 | Q2 2022 Sep 30, 2021 | Q1 2022 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 30.21K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -30.21K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -47.84M | -47.86M | -41.18M | -40.3M | -24.62M | -33.27M | -32.2M | -57.95M | -14.85M | -25.2M | -27.02M | -13.91M | -12.71M | -13.7M | -12.09M | -12.33M | -13.4M | -16.34M | -16.46M | -17.11M | -13.94M |
Interest Income | 1.25M | 1.58M | 1.5M | 1.49M | 700.95K | 1.44M | 1.68M | 3.06M | 1.57M | 342K | 141K | 52K | 84K | 148K | 157K | 174K | 124K | 83K | 63K | 51K | 44K |
Pretax Income | -46.6M | -47M | -42.63M | -47.03M | -24.61M | -30.58M | -10.84M | -56.9M | -10.83M | -21.35M | -30.33M | -11.89M | -14.51M | -13.72M | -10.74M | -9.97M | -13.06M | -18.1M | -17.21M | -17.61M | -14.72M |
Net Income | -46.6M | -47M | -42.63M | -47.03M | -24.61M | -30.58M | -10.84M | -56.9M | -10.83M | -21.35M | -30.33M | -11.89M | -14.51M | -13.72M | -10.74M | -9.97M | -13.06M | -18.1M | -17.21M | -17.61M | -14.72M |
Selling & General & Admin | 17.83M | 18.97M | 17.34M | 14.01M | 9.63M | 14.3M | 12.88M | 48.89M | 8.97M | 13.35M | 19.38M | 6.93M | 6.12M | 5.61M | 5.77M | 6.9M | 7.1M | 10.33M | 10.88M | 12.37M | 10.45M |
Research & Development | 29.98M | 28.89M | 23.84M | 26.29M | 14.99M | 18.97M | 19.32M | 9.07M | 5.88M | 11.84M | 7.64M | 6.98M | 6.59M | 8.09M | 6.33M | 5.43M | 6.3M | 6.01M | 5.58M | 4.74M | 3.49M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 47.81M | 47.86M | 41.18M | 40.3M | 24.62M | 33.27M | 32.2M | 57.95M | 14.85M | 25.2M | 27.02M | 13.91M | 12.71M | 13.7M | 12.09M | 12.33M | 13.4M | 16.34M | 16.46M | 17.11M | 13.94M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 4.65M | 1.07M | 486.76K | 752.82K | 3.11M | 625.57K | 918.76K | 31K | 1.85M | 23K | 15K | 12K | 12K | 66K | 90K | 713K | 312K | 399K | 405K | 350K |
Cost & Expenses | 47.84M | 47.86M | 41.18M | 40.3M | 24.62M | 33.27M | 32.2M | 57.95M | 14.85M | 25.2M | 27.02M | 13.91M | 12.71M | 13.7M | 12.09M | 12.33M | 13.4M | 16.34M | 16.46M | 17.11M | 13.94M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 52.32M | 50.29M | 24.21M | 24.21M | 22.4M | 20.9M | 20M | 20M | 19.59M | 20M | 8.78M | 6.17M | 5.43M | 5.16M | 4.97M | 4.76M | 4.63M | 4.58M | 4.52M | 4.36M | 4.15M |
Shares Outstanding (Diluted) | 52.32M | 50.29M | 24.21M | 24.21M | 22.4M | 20.9M | 20M | 20M | 19.59M | 20M | 8.78M | 6.17M | 5.43M | 5.16M | 4.97M | 4.76M | 4.63M | 4.58M | 4.52M | 4.36M | 4.15M |
EPS (Basic) | -0.89 | -0.92 | -1.76 | -1.94 | -1.10 | -1.46 | -0.54 | -2.84 | -0.55 | -1.07 | -3.45 | -1.93 | -2.68 | -2.66 | -2.16 | -2.10 | -2.82 | -3.96 | -3.81 | -4.04 | -3.55 |
EPS (Diluted) | -0.89 | -0.92 | -1.76 | -1.94 | -1.10 | -1.46 | -0.54 | -2.84 | -0.55 | -1.07 | -3.45 | -1.93 | -2.68 | -2.66 | -2.16 | -2.10 | -2.82 | -3.96 | -3.81 | -4.04 | -3.55 |
EBITDA | -47.81M | -47.83M | -41.15M | -40.26M | -24.58M | -33.21M | -32.06M | -57.81M | -14.75M | -25.05M | -26.88M | -13.84M | -12.64M | -13.64M | -12.02M | -12.27M | -13.34M | -16.29M | -16.41M | -17.06M | -13.9M |
EBIT | -47.84M | -47.86M | -41.18M | -40.3M | -24.62M | -33.27M | -32.2M | -57.95M | -14.85M | -25.2M | -27.02M | -13.91M | -12.71M | -13.7M | -12.09M | -12.33M | -13.4M | -16.34M | -16.46M | -17.11M | -13.94M |
Depreciation & Amortization | 30.21K | 31K | 21.98K | 40.45K | 33.99K | 62K | 135.18K | 142.5K | 101K | 142K | 142K | 71K | 69K | 68K | 71K | 59K | 53K | 44K | 44K | 42K | 38K |
Add to Watchlist
Select watchlists to add or remove HELP